Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Cost-effectiveness of Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients at Risk of Bleeding: a Real-world Cohort Study

NCT06443905 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT06443905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06443905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Cost-effectiveness of Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients at Risk of Bleeding: a Real-world Cohort Study
Lead sponsor
China-Japan Friendship Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2023
Completion date
December 30, 2024
Enrollment
21,600 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism, venous thromboembolism (vte)